Pyrrolidinium,2-[[(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxy]methyl]-1,1-dimethyl-, bromide(1:1) cas no:561-43-3

NamePyrrolidinium,2-[[(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxy]methyl]-1,1-dimethyl-, bromide(1:1)
CAS561-43-3
Synonyms2-(Hydroxymethyl)-1,1-dimethylpyrrolidiniumbromide, a-phenylcyclohexaneglycolate(6CI,7CI); Pyrrolidinium, 2-(hydroxymethyl)-1,1-dimethyl-, bromide, a-phenylcyclohexaneglycolate(8CI); Pyrrolidinium,2-[[(cyclohexylhydroxyphenylacetyl)oxy]methyl]-1,1-dimethyl-, bromide (9CI);2-(2-Hydroxyethyl)-1,1-dimethylpyrrolidinium bromide a-phenylcyclohexaneglycolate; BM3055; BRL 556; Imetro; Immetropan; LD 3055; Oxypyrronium; Oxypyrronium bromide
EINECS(EC#)209-219-8
Molecular FormulaC21H32 N O3 . Br
Molecular Weight426.45

Safety

Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of Br⁻and NO_x.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intravenous	18mg/kg (18mg/kg)		Archives Internationales de Pharmacodynamie et de Therapie. Vol. 147, Pg. 552, 1964.
mouse	LD50	oral	1040mg/kg (1040mg/kg)		Archives Internationales de Pharmacodynamie et de Therapie. Vol. 147, Pg. 552, 1964.
mouse	LD50	subcutaneous	303mg/kg (303mg/kg)		Archives Internationales de Pharmacodynamie et de Therapie. Vol. 147, Pg. 552, 1964.
rat	LD50	intraperitoneal	125mg/kg (125mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 1, Pg. 168, 1967.
rat	LD50	intravenous	27500ug/kg (27.5mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 1, Pg. 168, 1967.
rat	LD50	oral	780mg/kg (780mg/kg)		Oyo Yakuri. Pharmacometrics. Vol. 1, Pg. 168, 1967.